Cargando…
LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma
Myeloid-derived suppressor cells (MDSCs) are expanded in tumor microenvironments, including that of Epstein–Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC). The link between MDSC expansion and EBV infection in NPC is unclear. Here, we show that EBV latent membrane protein 1 (LMP1) promote...
Autores principales: | Cai, Ting-Ting, Ye, Shu-Biao, Liu, Yi-Na, He, Jia, Chen, Qiu-Yan, Mai, Hai-Qiang, Zhang, Chuan-Xia, Cui, Jun, Zhang, Xiao-Shi, Busson, Pierre, Zeng, Yi-Xin, Li, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540616/ https://www.ncbi.nlm.nih.gov/pubmed/28732079 http://dx.doi.org/10.1371/journal.ppat.1006503 |
Ejemplares similares
-
Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy
por: Xiao, L, et al.
Publicado: (2014) -
Molecular Screening of Nasopharyngeal Carcinoma: Detection of LMP-1, LMP-2 Gene Expression in Vietnamese Nasopharyngeal Swab Samples
por: Lao, Thuan Duc, et al.
Publicado: (2019) -
Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis
por: Jian, Shiou-Ling, et al.
Publicado: (2017) -
A lipid-based LMP2-mRNA vaccine to treat nasopharyngeal carcinoma
por: Guo, Mengran, et al.
Publicado: (2023) -
Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma
por: Kamara, Saidu, et al.
Publicado: (2023)